Use of radical cystectomy for patients with invasive bladder cancer

Journal of the National Cancer Institute

Volumn 102, Issue 11, 2010, Pages 802-811

  Gore, John L ^a,b,c   Litwin, Mark S ^b,c   Lai, Julie ^c   Yano, Elizabeth M ^d   Madison, Rodger ^c   Setodji, Claude ^c   Adams, John L ^c   Saigal, Christopher S ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER PATIENT; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CYSTECTOMY; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORD LINKAGE; MEDICARE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 77953227250     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq121     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Montie JE, Clark PE, Eisenberger MA, et al. Bladder cancer. J Natl Compr Canc Netw. 2009;7(1):8-39.
3. Schoenberg MP, Gonzalgo ML. Management of invasive and metastatic bladder cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: Saunders; 2006:2468-2478.
4. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Montie JE, Wei JT. The regionalization of radical cystectomy to specifc medical centers. J Urol. 2005;174(4, pt 1):1385-1389; discussion 1389.
5. Montie JE, Abrahams NA, Bahnson RR, et al. Bladder cancer. Clinical guidelines in oncology. J Natl Compr Canc Netw. 2006;4(10):984-1014.
6. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748.
7. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
8. Hofferkamp JE. Standards for Cancer Registries VolumeIII: Standards for Completeness, Quality, Analysis, Management, Security, and Confdentiality of Data. Springfeld, IL: North American Association of Central Cancer Registries; 2008.
9. ICD-9-CM International Classifcation of Diseases, Ninth Revision, Clinical Modifcation, Sixth Edition [computer program]. Version Offcial. Washington, DC: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Health Care Financing Administration; 1997.
10. American Medical Association. Current Procedural Terminology: CPTStandard Edition. Chicago, IL: American Medical Association; 1998.
11. Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare benefciaries, controlling for sociodemographic factors. Health Serv Res. 2000;34(6):1351-1362.
12. Kravet SJ, Shore AD, Miller R, Green GB, Kolodner K, Wright SM. Health care utilization and the proportion of primary care physicians. Am J Med. 2008;121(2):142-148. (Pubitemid 351199471)
13. Wennberg J, Gittelsohn A. Small area variations in health care delivery. Science. 1973;182(117):1102-1108.
14. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82(5):703-710.
15. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341-378.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
18. Best AE. Secondary data bases and their use in outcomes research: a review of the area resource fle and the Healthcare Cost and Utilization Project. J Med Syst. 1999;23(3):175-181.
19. Haynes R, Jones AP, Sauerzapf V, Zhao H. Validation of travel times to hospital estimated by GIS. Int J Health Geogr. 2006;5:40.
20. Finlayson SR, Birkmeyer JD, Tosteson AN, Nease RF Jr. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37(2):204-209.
21. Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D. Geographic access to cancer care in the U.S. Cancer. 2008;112(4):909-918.
22. Miller DC, Saigal CS, Banerjee M, Hanley J, Litwin MS. Diffusion of surgical innovation among patients with kidney cancer. Cancer. 2008;112(8):1708-1717.
23. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. London, UK: Sage Publications; 1999.
24. Subramanian S, Jones K, Duncan C. Multilevel methods for public health research. In: Kawachi I, Berkman LF, eds. Neighborhoods and Health. Oxford, UK: Oxford University Press; 2003:65-111.
25. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34.
26. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297(3):278-285.
27. Terza JV, Bradford WD, Dismuke CE. The use of linear instrumental variables methods in health services research and health economics: a cautionary note. Health Serv Res. 2008;43(3):1102-1120.
28. Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):531-543.
29. Wooldridge JM. Introductory Econometrics: A Modern Approach. 3rd ed. Mason, OH: Thomson/South-Western; 2006.
30. Scher H, Bahnson R, Cohen S, et al. NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park). 1998;12(7A):225-271.
31. Lotan Y, Cadeddu JA, Roehrborn CG, Stage KH. The value of your time: evaluation of effects of changes in Medicare reimbursement rates on the practice of urology. J Urol. 2004;172(5, pt 1):1958-1962.
32. Dahl DM, McDougal WS. Use of intestinal segments in urinary diversion. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: Saunders; 2006: 2534-2578.
33. Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Montie JE, Wei JT. Regionalization of radical cystectomy. J Urol. 2004;171(4 suppl):36. Abstract 137.
34. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15): 1128-1137.
35. Hollenbeck BK, Wei Y, Birkmeyer JD. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology. 2007;69(5): 871-875.
36. Konety BR, Dhawan V, Allareddy V, Joslyn SA. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol. 2005;173(5):1695-1700.
37. Ryoo JJ, Kunitake H, Frencher SK, et al. Continuity of care: readmission to the same hospital following gastric cancer resection. J Am Coll Surg. 2009;209(3):S16-17.
38. Baldwin LM, Cai Y, Larson EH, et al. Access to cancer services for rural colorectal cancer patients. J Rural Health. 2008;24(4):390-399.
39. Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL Jr. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23(28):7074-7080.
40. Tropman SE, Ricketts TC, Paskett E, Hatzell TA, Cooper MR, Aldrich T. Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat. 1999;56(1):59-66.
41. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer. 2008;44(7):992-999.
42. Virnig BA, Moscovice IS, Durham SB, Casey MM. Do rural elders have limited access to Medicare hospice services? J Am Geriatr Soc. 2004;52(5): 731-735.
43. Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263-270.
44. Konety BR, Joslyn SA. Factors infuencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170(5): 1765-1771.
45. Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer. 2005;103(3):546-552.
46. Hollenbeck BK, Miller DC, Taub D, et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology. 2004;64(2):292-297.
47. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10-30.
48. Gilbert SM, Wood DP, Dunn RL, et al. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer. 2007;109(9):1756-1762.
49. Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol. 2003;43(3):246-257.
50. Hayter CR, Paszat LF, Groome PA, Schulze K, Mackillop WJ. The management and outcome of bladder carcinoma in Ontario, 1982-1994. Cancer. 2000;89(1):142-151.
51. Munro NP, Sundaram SK, Weston PM, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK [published online ahead of print August 6, 2009]. Int J Radiat Oncol Biol Phys. 2009; doi:10.1016/j.ijrobp.2009.04.050.
52. Scrimger RA, Murtha AD, Parliament MB, et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys. 2001;51(1):23-30.